In drug rechallenge series, most subjects exhibited hepatocellular injury, jaundice, and/or hepatitis symptoms.1, 2, 4 Antibiotics, antiretrovirals, azathioprine, H2 antagonists, and 5-HT3 antagonists were the most frequently implicated medications in rechallenge injury. Most drug rechallenges were inadvertent. Most rechallenge events occur more rapidly than primary injury: 40 days to rechallenge injury versus 93 days for primary injury in prospective studies,4 and liver injury appearing within 1 week of rechallenge in nearly half of patients in a retrospective

series (and within hours in 2 of 88 patients, exhibiting predominantly immunoallergic injury).2 Although C646 mw most patients had jaundice or hepatitis symptoms with the initial or rechallenge liver injury, asymptomatic

liver chemistry elevations were reported in >50% of patients upon rechallenge, and jaundice or hepatitis symptoms were reported less commonly on rechallenge than the initial liver event in a retrospective Venetoclax ic50 series.2 Positive rechallenge events were observed over a broad age range (6 months to 83 years) and at generally similar rates in both sexes.2, 4 Many drugs with positive or fatal rechallenge are associated with mitochondrial impairment, hypersensitivity, or immunoallergic injury, hepatocellular injury, reactive metabolites, and high dose. Rechallenge data for seven drugs are outlined in Table 1. Halothane rechallenge is associated with the highest fatality rate, approaching 50% in two case series when rechallenge occurred within 1

month of anesthesia complicated by halothane-associated jaundice.3 Females and obese subjects exhibit an increased susceptibility to injury.28 Postulated mechanisms of halothane liver injury include both immunoallergic injury/hypersensitivity and mitochondrial impairment. Halothane is oxidized to a trifluoroacetyl halide, which forms protein adducts,24, 28 and it forms a free radical in hypoxic conditions.29 Fatal halothane rechallenge is widely attributed to immunomediated liver injury with rapid injury with rechallenge, associated fever, eosinophilia, anti-CYP2E1, anti–liver-kidney-microsomal and adduct antibodies,24, 28 and association with HLA A-11.29 Halothane also causes mitochondrial impairment, due to inhibition of complex I and II,30 as well as fatty acid and pyruvate oxidation in nonclinical studies.31 medchemexpress Therefore, halothane’s high fatality rate on rechallenge appears related to its combined mitochondrial impairment and immunoallergic injury, most frequently observed with rechallenge occurring within 1 month of initial injury. Tacrine, a cholinesterase inhibitor for Alzheimer’s disease, is associated with a 33% positive rechallenge rate. Asymptomatic liver injury is commonly observed with initial tacrine treatment, with 6% of subjects exhibiting ALT exceeding 10× ULN and 25% of subjects with ALT exceeding 3× ULN in controlled clinical trials.